
浏览全部资源
扫码关注微信
郑州大学附属儿童医院新生儿内科
纸质出版日期:2022,
扫 描 看 全 文
师淑锋, 李晶, 王孝勇. 不同严重程度高胆红素血症新生儿血清AST、CK-MB、LDH、BUN、TBiL水平的表达及临床意义[J]. 保健医学研究与实践, 2022,19(1):72-75.
Shi Shufeng, Li Jing, Wang Xiaoyong. Expression and clinical significance of AST,CK-MB,LDH,BUN and TBiL levels in neonates with different severity of hyperbilirubinemia[J]. Health Medicine Research and Practice, 2022,19(1):72-75.
师淑锋, 李晶, 王孝勇. 不同严重程度高胆红素血症新生儿血清AST、CK-MB、LDH、BUN、TBiL水平的表达及临床意义[J]. 保健医学研究与实践, 2022,19(1):72-75. DOI:
Shi Shufeng, Li Jing, Wang Xiaoyong. Expression and clinical significance of AST,CK-MB,LDH,BUN and TBiL levels in neonates with different severity of hyperbilirubinemia[J]. Health Medicine Research and Practice, 2022,19(1):72-75. DOI:
目的探讨不同严重程度高胆红素血症新生儿血清总胆红素(TBiL)、谷草转氨酶(AST)、血尿素氮(BUN)、肌酸激酶同工酶(CKMB)及乳酸脱氢酶(LDH)水平的表达及临床意义
旨在为临床高胆红素血症新生儿的诊治以及预后评估提供参考。方法选择2020年4月-2021年4月在郑州市某医院就诊的65例高胆红素血症新生儿作为观察组
选择同期行实验室指标检测的63例健康新生儿作为对照组。观察组患儿根据血清TBiL水平分为重度(TBiL水平>342μmol/L)8例
中度(257~342μmol/L)21例
轻度(TBiL水平<257μmol/L)36例。所有研究对象均进行实验室检测
指标包括AST、CKMB、LDH、BUN、TBiL。对比2组研究对象血清相关实验室检测指标:观察组、对照组的AST、CKMB、LDH、BUN、TBiL水平。对比治疗前后24 h轻度、中度、重度患儿AST、CKMB、LDH、BUN、TBiL水平。对比不同病情患儿预后情况
即统计治疗过程中的并发症发生率。结果观察组研究对象AST、CKMB、LDH、TBiL水平均高于对照组
差异均有统计学意义(P<0.05)。2组研究对象BUN水平比较
差异无统计学意义(P>0.05)。治疗前
中、轻度患儿AST、CKMB、LDH、TBiL水平均低于重度组
轻度组患儿AST、CKMB、LDH、TBiL水平均低于中度组
差异均有统计学意义(P<0.05)。治疗后
3组患儿AST、CKMB、LDH、TBiL水平均低于治疗前
差异均有统计学意义(P<0.05)。中、轻度组患儿AST、CKMB、LDH、TBiL水平均低于重度组
轻度组患儿AST、CKMB、LDH、TBiL水平均低于中度组
差异均有统计学意义(P<0.05)。中、轻度组患儿并发症发生率低于重度组
差异有统计学意义(P<0.05)。轻、中度组患儿并发症发生率比较
差异无统计学意义(P>0.05)。结论 AST、CK-MB、LDH、TBiL联合检测可用于评判高胆红素血症新生儿的病情严重程度
并可指导临床治疗
改善预后质量
值得临床推广。
Objective To investigate the expression and clinical significance of serum total bilirubin(TBiL)
aspartate aminotransferase(AST)
blood urea nitrogen(BUN)
creatine kinase myocardial band(CKMB) and lactate dehydrogenase(LDH) levels in neonates with different severity of hyperbilirubinemia
with the aim of providing reference for the diagnosis and treatment as well as prognostic assessment of neonates with hyperbilirubinemia in clinical practice.Methods Sixty-five neonates with hyperbilirubinemia attending a hospital in Zhengzhou from April 2020 to April 2021 were selected as the observation group
and 63 healthy neonates with laboratory indexes tested at the same period were selected as the control group.The children in the observation group were divided into 8 cases with severe(TBiL level >342 μmol/L)
21 cases with moderate(257~342 μmol/L)
and 36 cases with mild(TBiL level <257 μmol/L) hyperbilirubinemia according to the severity of the disease.All study subjects underwent laboratory tests
and the indexes included AST
CKMB
LDH
BUN
and TBiL.Serum-related laboratory test indexes were compared between the 2 groups:AST
CKMB
LDH
BUN
and TBiL levels were recorded in the observation and control groups.The levels of AST
CKMB
LDH
BUN and TBiL inchildren with mild
moderate and severe disease were compared before and after 24 h of treatment.The prognosis of children with different conditions was compared
the incidence of complications during the treatment was counted.Results The levels of AST
CKMB
LDH
and TBiL inthe observation group were lower than those in the control group
and the differences were statistically significant(P<0.05).The differences were not statistically significant(P>0.05) when comparing the BUN levels in the 2 groups.Before treatment
the levels of AST
CKMB
LDH
and TBiL were lower in the moderate and mild groups than in the severe group
and the higher of AST
CKMB
LDH
and TBiL were lower in the mild group than in the moderate group
and the differences were all statistically significant(P<0.05).After treatment
the levels of AST
CKMB
LDH and TBiL ofchildren in the three groups were lower than those before treatment
and the differences were all statistically significant(P<0.05).The levels of AST
CKMB
LDH and TBiL ofchildren in the moderate and mild groups were lower than those in the severe group
and the levels of AST
CKMB
LDH and TBiL ofchildren in the mild group were lower than those in the moderate group
and the differences were all statistically significant(P<0.05).The complication rates of children in the moderate and mild groups were lower than those in the severe group
and the differences were statistically significant(P <0.05).There was no statistically significant difference between the complication rates of children in the mild and moderate groups(P >0.05).Conclusion The combined test of AST
CK-MB
LDH and TBiL iseffective in the clinical management of neonates with hyperbilirubinemia
which can effectively identify the severity of the disease
guide clinical treatment and improve the quality of prognosis
and is worthy of clinical promotion.
高胆红素血症新生儿预后质量诊治效果病情程度
HyperbilirubinemiaNeonatePrognosis qualityDiagnosis and treatment effectDegree of disease
0
浏览量
114
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621